“I don't have Huntington's disease”: the boundaries between acceptance and understanding

 

 Permissions and Reprints

Abstract

Huntington's disease (HD) is an inherited disease that leads to an inexorable progression of motor, cognitive and psychiatric disturbances. In the initial stages, the symptoms are not clearly disabling, and the patient may present a lack of awareness about the symptoms themselves, which we call anosognosia. However, anosognosia might not justify all passivity of the HD patient in face of the diagnosis. Patients may also experience the denial of illness, as a stage of grief, expected to happen in the face of the diagnosis of any neurodegenerative disorder. In addition, people with HD tend to be more apathetic, and more silent, in regular consultations. In the present article, the authors express a point of view, discussing the behavior of the HD patient, in which there is a multifactorial passivity, in the face of the diagnosis and of the disease itself. Having the proper knowledge of this situation may prepare the neurologist to better understand the patient and the evolution of the disease.

Resumo

A doença de Huntington (DH) é uma doença hereditária que leva a uma progressão inexorável de distúrbios motores, cognitivos e psiquiátricos. Nos estágios iniciais, os sintomas não são claramente incapacitantes e há uma falta de consciência sobre os próprios sintomas, o que chamamos de anosognosia. No entanto, anosognosia pode não justificar toda a passividade do paciente de HD diante do diagnóstico. Os pacientes também podem vivenciar a negação da doença, como um estágio de luto, o que é esperado acontecer diante do diagnóstico de qualquer doença neurodegenerativa. Além disso, as pessoas com DH tendem a ficar mais apáticas, mais silenciosas, nas consultas regulares. No presente artigo, os autores expressam um ponto de vista, discutindo acerca do comportamento do paciente com DH, em que há uma passividade multifatorial, frente ao diagnóstico e diante da doença em si. Ter conhecimento sobre essa situação pode preparar o neurologista para entender melhor o paciente e a evolução da doença.

Authors' Contributions

GLF: conceptualization, methodology, writing – original draft, writing – review & editing; HAGT: conceptualization, supervision, writing – original draft, writing – review & editing; FEC: supervision, visualization, writing – original draft, writing – review & editing.

Publication History

Received: 19 October 2022

Accepted: 09 January 2023

Article published online:
26 July 2023

© 2023. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

• References

• 1 Ross CA, Aylward EH, Wild EJ. et al. Huntington's disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 2014; 10 (04) 204-216 DOI: 10.1038/nrneurol.2014.24.
  CrossrefPubMedGoogle Scholar
• 2 Squitieri F, Berardelli A, Nargi E. et al. Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis. Clin Genet 2000; 58 (01) 50-56 DOI: 10.1034/j.1399-0004.2000.580108.x.
  CrossrefPubMedGoogle Scholar
• 3 Becker N, Munhoz RP, Raskin S, Werneck LC, Teive HA. Non-choreic movement disorders as initial manifestations of Huntington's disease. Arq Neuropsiquiatr 2007; 65 (2B): 402-405 DOI: 10.1590/s0004-282X2007000300007.
  CrossrefPubMedGoogle Scholar
• 4 Franklin GL, Camargo CHF, Meira AT. et al. Is Ataxia an Underestimated Symptom of Huntington's Disease?. Front Neurol 2020; 11: 571843 DOI: 10.3389/fneur.2020.571843.
  CrossrefPubMedGoogle Scholar
• 5 Youssov K, Audureau E, Vandendriessche H. et al. The burden of Huntington's disease: A prospective longitudinal study of patient/caregiver pairs. Parkinsonism Relat Disord 2022; 103: 77-84 DOI: 10.1016/j.parkreldis.2022.08.023.
  CrossrefPubMedGoogle Scholar
• 6 Franklin GL, Ferreira CH, Teive HAG. It Is Time to Define Huntington's Disease Onset more Clearly. Mov Disord Clin Pract (Hoboken) 2021; 8 (03) 493-494 DOI: 10.1002/mdc3.13174.
  CrossrefPubMedGoogle Scholar
• 7 Babinski J. Contribution à l'étude des troubles, mentaux dans l'hémiplégie organique cérebrale (Anosognosie). Rev Neurol (Paris) 1914; 27: 845-848
  Google Scholar
• 8 Frankenburg FR. A variation of Capgras syndrome with anosognosia in Huntington's disease: a case report. Hillside J Clin Psychiatry 1989; 11 (02) 121-126
  PubMedGoogle Scholar
• 9 Isaacs D, Gibson JS, Stovall J, Claassen DO. The Impact of Anosognosia on Clinical and Patient-Reported Assessments of Psychiatric Symptoms in Huntington's Disease. J Huntingtons Dis 2020; 9 (03) 291-302 DOI: 10.3233/JHD-200410.
  CrossrefPubMedGoogle Scholar
• 10 McCusker EA, Gunn DG, Epping EA. et al; PREDICT-HD Investigators of the Huntington Study Group. Unawareness of motor phenoconversion in Huntington disease. Neurology 2013; 81 (13) 1141-1147
  CrossrefPubMedGoogle Scholar
• 11 Biglan KM, Ross CA, Langbehn DR. et al; PREDICT-HD Investigators of the Huntington Study Group. Motor abnormalities in premanifest persons with Huntington's disease: the PREDICT-HD study. Mov Disord 2009; 24 (12) 1763-1772 DOI: 10.1002/mds.22601.
  CrossrefPubMedGoogle Scholar
• 12 Duff K, Paulsen JS, Beglinger LJ. et al; Predict-HD Investigators of the Huntington Study Group. “Frontal” behaviors before the diagnosis of Huntington's disease and their relationship to markers of disease progression: evidence of early lack of awareness. J Neuropsychiatry Clin Neurosci 2010; 22 (02) 196-207
  CrossrefPubMedGoogle Scholar
• 13 Wibawa P, Zombor R, Dragovic M. et al. Anosognosia Is Associated With Greater Caregiver Burden and Poorer Executive Function in Huntington Disease. J Geriatr Psychiatry Neurol 2020; 33 (01) 52-58 DOI: 10.1177/0891988719856697.
  CrossrefPubMedGoogle Scholar
• 14 McCusker E, Loy CT. The many facets of unawareness in huntington disease. Tremor Other Hyperkinet Mov (N Y) 2014; 4: 257 DOI: 10.7916/D8FJ2FD3.
  CrossrefPubMedGoogle Scholar
• 15 Sitek EJ, Thompson JC, Craufurd D, Snowden JS. Unawareness of deficits in Huntington's disease. J Huntingtons Dis 2014; 3 (02) 125-135 DOI: 10.3233/JHD-140109.
  CrossrefPubMedGoogle Scholar
• 16 Pennington C, Duncan G, Ritchie C. Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review. Int J Geriatr Psychiatry 2021; 36 (01) 15-30 DOI: 10.1002/gps.5415.
  CrossrefPubMedGoogle Scholar
• 17 Castro PC, Aquino CC, Felício AC. et al. Presence or absence of cognitive complaints in Parkinson's disease: mood disorder or anosognosia?. Arq Neuropsiquiatr 2016; 74 (06) 439-444 DOI: 10.1590/0004-282X20160060.
  Article in Thieme ConnectPubMedGoogle Scholar
• 18 Sitek EJ, Sołtan W, Wieczorek D. et al. Self-awareness of motor dysfunction in patients with Huntington's disease in comparison to Parkinson's disease and cervical dystonia. J Int Neuropsychol Soc 2011; 17 (05) 788-795 DOI: 10.1017/S1355617711000725.
  CrossrefPubMedGoogle Scholar
• 19 Klubler-Ross E. On Death and Dying. New York: Macmillan Publishing Co; 1969
  Google Scholar
• 20 Deckel AW, Morrison D. Evidence of a neurologically based “denial of illness” in patients with Huntington's disease. Arch Clin Neuropsychol 1996; 11 (04) 295-302
  CrossrefPubMedGoogle Scholar
• 21 Chatterjee A, Anderson KE, Moskowitz CB, Hauser WA, Marder KS. A comparison of self-report and caregiver assessment of depression, apathy, and irritability in Huntington's disease. J Neuropsychiatry Clin Neurosci 2005; 17 (03) 378-383
  CrossrefPubMedGoogle Scholar